Skip links

SEPHIENCE™ (sepiapterin)

Full Name SEPHIENCE (sepiapterin)
Drug sepiapterin
Manufacturer PTC Therapeutics
Route of Administration Oral
Site of Care Home
Approved Indication Treatment of hyperphenylalaninemia (HPA) in adult and pediatric patients 1 month of age and older with sepiapterin-responsive phenylketonuria (PKU)
Disease Phenylketonuria (PKU)
Therapeutic Area Endocrinology
Enrollment Form Link Enrollment Form
Phone Number (847) 521-4499
Fax Number (888) 726-9306
Product Website sephience.com
Patient Resources National PKU Alliance